Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Original Paper
  • Published:

Inhibition of MT-450 rat mammary tumour growth by antibodies recognising subtypes of blood group antigen B

Oncogene volume 18, pages 4485–4494 (1999)Cite this article

Abstract

Using subtractive immunization to identify cell surface epitopes expressed in a metastasis-specific fashion on cells of the rat MT-W9 mammary carcinoma model, we generated a monoclonal antibody called M-N#1. This antibody binds specifically to metastasizing cells of the MT-W9 series and also to certain other metastasizing rat mammary carcinoma cell lines. We demonstrate that the M-N#1 antibody recognizes a fucosylated N-glycosyl sugar modification, and furthermore show that the epitope specificity of the M-N#1 antibody is for blood group antigen B subtypes 2, 3 and 4 with slight cross-reactivity with blood group antigen A subtype 2. The expression of these carbohydrate epitopes on MT-450 cells is functionally important, because the M-N#1 antibody efficiently inhibits MT-450 tumour growth in spontaneous metastasis assays. These results suggest that expression of the subtypes of blood group antigen B recognized by the M-N#1 antibody does not directly participate in the metastatic cascade but rather confers a growth or survival advantage on the tumour cells.

This is a preview of subscription content, access via your institution

Access options

Buy this article

  • Purchase on SpringerLink
  • Instant access to the full article PDF.

USD 39.95

Prices may be subject to local taxes which are calculated during checkout

Figure 1
Figure 2
Figure 3
Figure 4
Figure 5
Figure 6
Figure 7

Similar content being viewed by others

References

  • Akahani S, Nangia-Makker P, Inohara H, Choi Kim H-R and Raz A. . 1997 Cancer Res. 57: 5272–5276.

  • Akiyama S, Yamada S and Yamada K. . 1989 J. Biol. Chem. 264: 18011–18018.

  • Brooks P, Lin J-M, French D and Quigley J. . 1993 J. Cell Biol. 122: 1351–1359.

  • Byrne G and Cox E. . 1986 Dev. Biol. 117: 442–455.

  • Chammas R, Veiga S, Line S, Potocnjak P and Brentani R. . 1991 J. Biol. Chem. 266: 3349–3355.

  • Chatterjee S and Kim U. . 1978 J. Natl. Cancer Inst. 61: 151–162.

  • Clausen H and Hakomori S. . 1989 Vox Sang 56: 1–20.

  • Dabelsteen E, Graem N, Clausen H and Hakomori S. . 1988 Cancer Res. 48: 181–187.

  • Dall P, Heider K-H, Sinn H-P, Skroch-Angel P, Adolf G, Kaufmann M, Herrlich P and Ponta H. . 1995 Int. J. Cancer 60: 471–477.

  • Denk H, Tappeiner G and Holzner J. . 1974 Eur. J. Cancer 10: 487–490.

  • Ghosh S, Roholt O and Kim U. . 1983 In Vitro 19: 919–928.

  • Goupille C, Hallouin F, Meflah K and LePendu J. . 1997 Glycobiology 7: 221–229.

  • Günthert U, Hofmann M, Rudy W, Reber S, Zöller M, Hauβmann I, Matzku S, Wenzel A, Ponta H and Herrlich P. . 1991 Cell 65: 13–24.

  • Hakomori S. . 1996 Cancer Res. 56: 5309–5318.

  • Hallouin F, Goupille C, LeCabellec M, Bara J and LePendu J. . 1998 Glycoconj. J. in press.

  • Harlow E and Lane D. . 1988 Cold Spring Harbor Laboratory Press: Cold Spring Harbor, New York.

    Google Scholar 

  • Holmes E. . 1990 Carcinogenesis 11: 89–94.

  • Ichikawa T, Ichikawa I, Dong J, Hawkins A, Griffin C, Isaacs W, Oshimura M, Barrett J and Isaacs J. . 1992 Cancer Res. 52: 3486–3490.

  • Ichikawa T, Ichikawa I and Isaacs J. . 1991 Cancer Res. 51: 3788–3792.

  • Isaacs J, Heston W, Weissman R and Coffey D. . 1978 Cancer Res. 38: 4353–4359.

  • Isaacs J, Isaacs W, Feitz W and Scheres J. . 1986 Prostate 9: 261–281.

  • Kim U. . 1986 J. Surgical Oncol. 33: 151–165.

  • King M-J. . 1994 Biochim. Biophys. Acta 1197: 15–44.

  • Labarriere N, Piau JP, Otry C, Dennis M, Lustenberger P, Meflah K and Le Pendu J. . 1994 Cancer Res. 54: 6275–6281.

  • Le Marer N and Hughes R. . 1996 J. Cell Physiol. 168: 51–58.

  • Lee A, DeLellis R, Rosen P, Saigo P, Gangi M, Bagin R, Groshen S and Wolfe H. . 1985 Am. J. Clin. Pathol. 83: 308–319.

  • Lichtner RB and Nicolson GL. . 1987 Invasion Metastasis 7: 73–82.

  • Miyake M, Taki T, Hitomi S and Hakomori S. . 1992 New England J. Med. 327: 14–18.

  • Neri A, Ruoslahti E and Nicolson GL. . 1981 Cancer Res. 41: 5082–5095.

  • Ogawa J, Inoue H and Koide S. . 1996 Cancer Res. 56: 325–329.

  • Oriol R, Cooper J, Davies D and Keeling P. . 1984 Lab. Invest. 50: 514–518.

  • Raz A, Zhu D, Hogan V, Shah N, Raz T, Karkash R, Pazerini G and Carmi P. . 1990 Int. J. Cancer 46: 871–877.

  • Rudy W, Hofmann M, Schwartz-Albiez R, Zöller M, Heider K-H, Ponta H and Herrlich P. . 1993 Cancer Res. 53: 1262–1268.

  • Sato S and Hughes RC. . 1992 J. Biol. Chem. 267: 6983–6990.

  • Schoentag R, Primus F and Kuhns W. . 1987 Cancer Res. 47: 1695–1700.

  • Sleeman JP. . 1993 Oncogene 8: 1931–1941.

  • Sleeman J, Rudy W, Hofmann M, Moll J, Herrlich P and Ponta H. . 1996 J. Cell Biol. 135: 1139–1150.

  • Strauchen J, Bergman S and Hanson T. . 1980 Cancer 45: 2149–2155.

  • Sun J, Thurin J, Cooper H, Wang P, Mackiewicz M, Steplewski Z and Blaszczyk-Thurin M. . 1995 Proc. Natl. Acad. Sci. USA 92: 5724–5728.

  • Ura Y, Dion A, Williams C, Olsen B, Redfield E, Ishida M, Herlyn M and Major P. . 1992 Int. J. Cancer 50: 57–63.

  • Verma M. . 1994 Cancer Biochem. Biophys. 14: 151–162.

  • Vermeersch Williams C, Stechmann V and McLoon S. . 1992 Biotechniques 12: 842–847.

  • Vowden P, Lowe A, Lennox E and Bleehen N. . 1986 Br. J. Cancer 53: 313–319.

  • Wang J, Ambros R, Weber P and Rosano T. . 1995 Cancer Res. 55: 3654–3658.

  • Xing R and Rabbani S. . 1996 Int. J. Cancer 67: 423–429.

  • Yang R-Y, Hsu D and Liu F-T. . 1996 Proc. Natl. Acad. Sci. USA 93: 6737–6742.

  • Yoshimura M, Ihara Y, Matsuzawa Y and Taniguchi N. . 1996 J. Biol. Chem. 271: 13811–13815.

  • Yuan M, Itzkowitz H, Palekar A, Shamsuddin A, Phelps P, Trump B and Kim Y. . 1985 Cancer Res. 45: 4499–4511.

  • Zheng M, Fang H and Hakomori S. . 1994 J. Biol. Chem. 269: 12325–12331.

Download references

Acknowledgements

We thank Uschi Rahmsdorf and Anja Steffen for excellent technical assistance and Martin Hofmann for critically reading the manuscript. This work was supported by the Deutsche Forschungsgemeinschaft (He 551/8-2) and Boehringer Ingelheim. JP Sleeman was supported by a European Union Marie Curie Fellowship.

Author information

Author notes

  1. Untae Kim

    Present address: Veterans Affairs Medical Center, Research Building, Room 219, 3495 Bailey Avenue, Buffalo, NY 14215, New York, USA

Authors and Affiliations

  1. Forschungszentrum Karlsruhe, Institute of Genetics, PO Box 3640, Karlsruhe, D-76021, Germany

    Jonathan P Sleeman, Untae Kim, Norma Howells, Thérèse Coquerelle, Helmut Ponta & Peter Herrlich

  2. INSERM U419, Institut de biologie, 9 Quai Moncousu, Nantes, Cedex, 44035, France

    Jacques LePendu

Authors
  1. Jonathan P Sleeman
    View author publications

    Search author on:PubMed Google Scholar

  2. Untae Kim
    View author publications

    Search author on:PubMed Google Scholar

  3. Jacques LePendu
    View author publications

    Search author on:PubMed Google Scholar

  4. Norma Howells
    View author publications

    Search author on:PubMed Google Scholar

  5. Thérèse Coquerelle
    View author publications

    Search author on:PubMed Google Scholar

  6. Helmut Ponta
    View author publications

    Search author on:PubMed Google Scholar

  7. Peter Herrlich
    View author publications

    Search author on:PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Sleeman, J., Kim, U., LePendu, J. et al. Inhibition of MT-450 rat mammary tumour growth by antibodies recognising subtypes of blood group antigen B. Oncogene 18, 4485–4494 (1999). https://doi.org/10.1038/sj.onc.1202808

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue date:

  • DOI: https://doi.org/10.1038/sj.onc.1202808

Keywords

This article is cited by

Search

Advanced search

Quick links